Session 2S

Structure-Functional Studies of Biological Systems

3:30 PM to 5:00 PM | Moderated by Ram Samudrala


The Evolution of the HIV Nef Accessory Protein in Cross-Species Transmission of HIV
Presenter
  • Kathryn Ann (Katie) Hooper, Senior, Biochemistry, Microbiology Mary Gates Scholar
Mentors
  • Michael Emerman, , Fred Hutchinson Cancer Center
  • Efrem Lim,
Session
  • 3:30 PM to 5:00 PM

The Evolution of the HIV Nef Accessory Protein in Cross-Species Transmission of HIVclose

Human Immunodeficiency Virus (HIV) is the result of cross-species transmission of Simian Immunodeficiency Virus (SIV) from chimpanzees to humans. One important adaptation of HIV to its human host is the evolution of a viral antagonist to the host restriction factor tetherin. Tetherin functions to block viral replication by keeping nascent virus particles tethered to the host cell surface. SIV is able to counteract chimpanzee tetherin using an accessory protein called Nef which targets a portion of the cytoplasmic tail of tetherin that is deleted in humans. As a result, upon cross-species transmission, HIV evolved to use the accessory protein Vpu as a human tetherin antagonist. Surprisingly, we have observed that HIV Nef has lost its ability to antagonize human tetherin, as well as chimpanzee tetherin. By constructing chimeric proteins of HIV and SIV Nef, we are seeking to map the region of Nef necessary for function against tetherin. The ability of these chimeras to antagonize chimpanzee tetherin has been tested by assaying for the release of murine leukemia virus that encodes a luciferase reporter gene. We have also used flow cytometry to confirm the chimeras’ ability to carry-out another important function of Nef, down-regulation of MHC Class I from the cell surface, using anti-MHC antibodies conjugated to a fluorophore. We then hypothesize that the region of HIV Nef that has evolved away from its previous tetherin antagonism role will have evolved new functions important for infection of the human host.


Genetic Impact of Vaccination on Breakthrough HIV-1 Sequences from the Step Trial
Presenter
  • Eleanor Jolene (Ellie) Westfall, Senior, Spanish, Microbiology
Mentors
  • James Mullins,
  • Heather Bouzek,
Session
  • 3:30 PM to 5:00 PM

Genetic Impact of Vaccination on Breakthrough HIV-1 Sequences from the Step Trialclose

In 2009, 2.6 million people became newly infected with Human Immunodeficiency Virus (HIV). While large advances in antiretroviral drug therapies have extended the lives of patients currently infected, attempts to engineer a vaccine to block infection by HIV have failed. One such effort, the “Step Study”, performed by Merck Research Laboratories and the HIV Vaccine Trials Network (HVTN) began in 2004 and was discontinued in 2007 when analysis showed that more vaccine recipients had become infected than placebo. Despite the vaccine’s failure to protect against viral infection, subsequent analysis showed the vaccine did indeed elicit a response from the cell-mediated immune system. Analysis of patient viruses, performed by the Mullins Lab and its collaborators, found the infecting viruses of vaccine recipients to be unusually divergent from the vaccine HIV sequence, when compared to the placebo group. This result indicates a vaccine-related genetic correlation. Two hypotheses may explain this divergence. The “sieve effect” suggests that infecting viruses with sequences similar to the HIV genes in the vaccine were blocked from entry by a primed cell-mediated immune response. The “selection effect” hypothesis contends that the vaccine-primed immune response exerted selective pressure on the infecting viruses and drove viral evolution. To elucidate the mechanism, samples of patient viruses, collected from various time-points throughout early infection, are amplified using nested Polymerase Chain Reaction (nPCR), and then sequenced by pyrosequencing, a technique that allows examination of the viral population at great depth. Analysis of these sequences by various statistical methods will then be done to calculate the divergence of patient viruses from vaccine epitopes, as well as viral mutation rates and overall variety within the population. Such analysis could distinguish the mechanism by which the vaccine impacted the infecting virus, providing insight into the generation of a more effective vaccine against HIV.


Detecting Polymorphisms in an Anti-HIV Gene that Functions in Chimpanzees but not Humans
Presenter
  • Shelley Y (Shelley) Leong, Senior, Microbiology
Mentors
  • Michael Emerman, , Fred Hutchinson Cancer Center
  • Nisha Duggal,
Session
  • 3:30 PM to 5:00 PM

Detecting Polymorphisms in an Anti-HIV Gene that Functions in Chimpanzees but not Humansclose

The APOBEC3 family of genes has antiviral activity against retroviruses such as HIV-1. APOBEC3DE (A3DE) is one member of this family that is very divergent between humans and chimpanzees. Although most primates possess a form of this advantageous protein, it’s antiviral activity varies across species. For example, the chimpanzee version of this protein can strongly inhibit HIV-1 replication, while human A3DE only inhibits HIV-1 weakly. The goal of this project is to determine what caused the different activities in chimp and human A3DE. Two to six million years ago, the chimp A3DE gene underwent a period of rapid evolution, selecting for non-synonymous single nucleotide polymorphisms into the gene. It is thought that during this time, chimps were uniquely pressured by a virus that selected for an increased activity in the A3DE gene. Recently, I sequenced the A3DE gene in a panel of ten chimps that showed a high ratio of non-synonymous to synonymous polymorphisms, suggesting that a more recent selection could also have occurred in chimp A3DE. A high mutational frequency in A3DE indicates that the amino acids of A3DE are changing, possibly altering the activity of the protein. Currently, a diverse panel of thirty human samples is being sequenced to look for non-synonymous polymorphisms in the A3DE gene. These polymorphisms will be used to determine the mutational frequency of A3DE in the current human population. Once these polymorphisms have been detected, they will be tested in functional assays to determine if they alter the human A3DE activity. This part of the project will help determine if the current human population possesses an active form of A3DE. This data will be interesting because if the human A3DE polymorphisms result in a more active antiviral protein, this will suggest that a recent selective pressure, like a virus, caused this change in the human population.


High Accuracy Scoring Functions for Computational Protein Structure Refinement
Presenter
  • Michael Duan (Michael) Zhou, Senior, Biochemistry, Computer Science Mary Gates Scholar
Mentor
  • Ram Samudrala,
Session
  • 3:30 PM to 5:00 PM

High Accuracy Scoring Functions for Computational Protein Structure Refinementclose

Predicting the three dimensional structure of a protein from amino acid sequence is still an unsolved problem in the field of computational biology. However, although native structure prediction is still not possible, methods such as Protinfo, Rosetta, and I-TASSER can produce near-native models that can be useful and informative. Refinement methods aim to improve upon the quality of these initially generated models, driving them closer to the native structure. Although the changes made to a protein structure with refinement methods are often small, they are very significant in terms of improving the potential for application of the modeled structure. This project aimed to improve the performance of our group’s refinement methods by creating a scoring function that is superior at selecting the best final models from the ones initially generated. Through machine learning, physical density scores and knowledge based statistical potentials from both the Cambridge Structural Database (CSD) and the Protein Data Bank (PDB) were combined into one overall model favorability score. Results demonstrate that this hybrid method has superior discrimination for near-native structures, suggesting that using this scoring function to drive structure refinement will result in models of higher accuracy. Thus the hybrid function can not only be used for improving computational protein structure prediction, but also has applications in the areas of computational protein design and prediction of protein ligand interactions.


Optimization of Protein Structure Prediction Software for EST Data
Presenter
  • Adrian Andrew Laurenzi, Junior, Computer Science, Biology (Ecology, Evolution & Conservation) Levinson Emerging Scholar, Mary Gates Scholar
Mentor
  • Ram Samudrala,
Session
  • 3:30 PM to 5:00 PM

Optimization of Protein Structure Prediction Software for EST Dataclose

Large public databases of Expressed Sequence Tags (ESTs) have been made available through projects such as the Gene Index Project at Harvard University by sequencing the expressed genes from a tremendous variety of organisms. To make efficient use of EST data computational techniques have been developed to analyze and organize EST databases. ESTs have been useful in discovering new genes, understanding gene expression and regulation, and constructing genome maps, all of which have important implications in medicine. However, the utility of EST data relies upon our ability to make accurate annotations that describe the functionality of the ESTs in the source organism. Presently most approaches used to annotate ESTs rely on sequence-based comparison methods such as BLAST. This is limiting because the function of a protein is dependent upon its tertiary (3-D) structure. Therefore, the ability to reliably predict the functionality of an EST could be improved if we were able to accurately predict the structure of the proteins that ESTs encode. We have demonstrated that ProtinfoAB and Rosetta can reliably predict the structures of parts of proteins encoded by sequences that contain approximately 75% or more of the full-length protein sequence suggesting these methods would be useful in annotating at least a subset of sequences from an EST database. We propose to optimize prediction of partial structures of proteins encoded by ESTs (EST structure) by combining ProtinfoAB, an ab initio method that predicts structures based on biochemical principles, and ProtinfoCM, a template-based method that relies upon previously solved structures to make predictions. Optimization of EST structure prediction will enhance our ability to accurately predict the functionality of ESTs which will enable researchers to design more informed bench experiments and expedite the discovery of new genes and gene networks with potential utility in medicine.


A Molecular Evolution Approach to Identifying a Transposable Element Suppressor in the Drosophila melanogaster Male Germline
Presenter
  • Kiana Mohajeri, Junior, Biology (Molecular, Cellular & Developmental)
Mentor
  • Mia Levine, , Fred Hutchinson Cancer Research Center
Session
  • 3:30 PM to 5:00 PM

A Molecular Evolution Approach to Identifying a Transposable Element Suppressor in the Drosophila melanogaster Male Germlineclose

The Heterochromatin protein 1 (HP1) gene family is comprised of multiple non-histone chromosomal proteins that support several essential cellular functions including chromosome segregation and gene regulation. HP1D, a member of the HP1 family, is an ovary restricted, rapidly evolving HP1, that contributes to the suppression of transposable elements in the female germline and could potentially be locked in genetic conflict with these parasitic elements of the genome. The presence of a male functional analog of HP1D, an HP1 responsible for silencing transposable elements in the male germline, has yet to be identified. One male specific HP1, HP1E, was identified as the only known full length HP1 in Drosophila melanogaster that is exclusively expressed in the male germline. I set out to test if HP1E is also evolving under positive selection, the presence of which would indicate a possibility for the gene’s involvement in genetic conflict in the male germline. After sequencing HP1E from multiple, closely related Drosophila species, I conducted a molecular evolution study that provided limited support for HP1E rapidly evolving under positive selection. This data suggests alternative pathway possibilities for the silencing of transposable elements in the male germline and that HP1E may instead be involved in a more conserved biological function.


Drug Cycling and the Evolutionary Trajectory of Antibiotic Resistance  
Presenter
  • Rachel Sobel, Senior, Biology (Ecology, Evolution & Conservation) Mary Gates Scholar
Mentor
  • Benjamin Kerr,
Session
  • 3:30 PM to 5:00 PM

Drug Cycling and the Evolutionary Trajectory of Antibiotic Resistance  close

The distribution of an organism's exposure to an environment has been demonstrated to dramatically impact its evolutionary trajectory. To investigate the details of this phenomenon, we performed a serial transfer experiment, using the interaction of E. coli bacteria and the antibiotic rifampicin as a model system. All treatment wells were given the same sum amount of the antibiotic over the course of a 32-day treatment period, cycling between one of several high drug-concentration environment and the corresponding lower drug-concentration environment with a number of different cycle lengths. We are interested in the effect of the different lengths and amplitudes of the drug treatment regimen on the resistance level and overall fitness of our evolved cultures.


The University of Washington is committed to providing access and accommodation in its services, programs, and activities. To make a request connected to a disability or health condition contact the Office of Undergraduate Research at undergradresearch@uw.edu or the Disability Services Office at least ten days in advance.